Related Experiment Videos
Pyothorax-associated lymphoma: a lymphoma developing in chronic inflammation
Katsuyuki Aozasa1, Tetsuya Takakuwa, Shin-ichi Nakatsuka
1Department of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan. aozasa@molpath.med.osaka-u.ac.jp
Advances in Anatomic Pathology
|December 7, 2005
Summary
Pyothorax-associated lymphoma (PAL) is a distinct B-cell cancer developing after long-term pyothorax. Epstein-Barr virus (EBV) infection and unique gene expression characterize this pleural malignancy.
Area of Science:
- Oncology
- Pathology
- Infectious Disease
Background:
- Pyothorax-associated lymphoma (PAL) is a rare non-Hodgkin lymphoma.
- It develops in the pleural cavity following a history of pyothorax, often from artificial pneumothorax treatment for tuberculosis.
- Common symptoms include chest pain and fever.
Purpose of the Study:
- To characterize the distinct clinicopathologic and molecular features of PAL.
- To investigate the association of PAL with Epstein-Barr virus (EBV).
- To differentiate PAL from nodal diffuse large B-cell lymphoma (DLBL).
Main Methods:
- Histological analysis of PAL, including B-cell and T-cell marker expression.
- Gene expression profiling to compare PAL with nodal DLBL.
- Detection of Epstein-Barr virus (EBV) latent genes.
Main Results:
- PAL typically presents as diffuse large B-cell lymphoma (DLBL) with aberrant B-cell and T-cell marker expression.
- PAL exhibits a distinct gene expression profile with higher levels of interferon-inducible genes compared to nodal DLBL.
- Strong association with EBV infection, with expression of EBV latent genes (EBNA-2, LMP-1, EBNA-1).
Conclusions:
- PAL is a distinct clinicopathologic entity.
- EBV infection, artificial pneumothorax history, and chronic inflammation likely contribute to PAL development.
- Understanding PAL's unique features is crucial for diagnosis and management.